Rare diseases
Investigational molecules
Locations
Study of fludarabine phosphate in patients with blood cancer undergoing lymphodepletion before CAR-T cell therapy
BelgiumStudy of ciltacabtagene autoleucel in patients with newly diagnosed multiple myeloma using a modified treatment preparation regimen
SpainStudy of Ciltacabtagene Autoleucel and Drug Combination for Treatment of High-Risk Smoldering Multiple Myeloma
SpainStudy Comparing Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone with Ciltacabtagene Autoleucel or Stem Cell Transplant for Newly Diagnosed Multiple Myeloma Patients
BelgiumLong-term Safety Study of Ciltacabtagene Autoleucel for Patients with Multiple Myeloma
BelgiumStudy of JNJ-68284528 for Treating Multiple Myeloma in Patients Using Ciltacabtagene Autoleucel and Drug Combination
BelgiumStudy Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma
BelgiumStudy Comparing Bortezomib, Lenalidomide, and Dexamethasone with Ciltacabtagene Autoleucel for Newly Diagnosed Multiple Myeloma Patients Not Planning Stem Cell Transplant
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
